Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Why the Combination Is Common Anyway The pairing is popular in research and clinic marketing because CJC-1295 and Ipamorelin target different growth-hormone signaling pathways: Compound Class Primary Pathway FDA Status CJC-1295 GHRH analog GHRH receptor signaling Not approved Ipamorelin GHRP / ghrelin mimetic GHS-R1a signaling Not approved CJC-1295 + Ipamorelin Combination research blend Dual pathway GH secretagogue model Not approved Mechanistic complementarity is not the same as regulatory approval
importantly, the Sstr2 has been found to be highly expressed in certain types of cancers (4850)
The company "must rethink its 'giant in the room' mentality and support their innovation teams to allow products to market much faster
Common topical formulation strengths Cosmetic and compounded topical GHK-Cu products typically range from 1% to 3% by weight
US$ 26.89
US$ 28.36
US$ 20.37
